allylamine has been researched along with Prediabetic State in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abby, SL; Hernandez-Triana, E; Jin, X; Jones, MR; Lai, YL; Misir, S; Mudaliar, S; Nagendran, S; Unnikrishnan, AG | 1 |
| Abby, SL; Donovan, JM; Handelsman, Y; Jin, X; Jones, MR | 1 |
| Jellinger, PS; Levy, P | 1 |
| Handelsman, Y; Hernandez-Triana, E; Jones, MR; Misir, S; Rosenstock, J | 1 |
| Goldberg, RB; Hernandez-Triana, E; Jones, MR; Misir, S; Rosenson, RS | 1 |
| Elisaf, MS; Florentin, M; Kei, AA; Kostapanos, MS; Liamis, G; Liberopoulos, EN; Rizos, CV | 1 |
1 review(s) available for allylamine and Prediabetic State
| Article | Year |
|---|---|
The potential role of colesevelam in the management of prediabetes and type 2 diabetes mellitus.
Topics: Administration, Oral; Aged; Allylamine; Anticholesteremic Agents; Blood Glucose; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Practice Guidelines as Topic; Prediabetic State; Prognosis; Severity of Illness Index; Treatment Outcome | 2010 |
4 trial(s) available for allylamine and Prediabetic State
| Article | Year |
|---|---|
Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
Topics: Adolescent; Adult; Aged; Algorithms; Allylamine; Anticholesteremic Agents; Clinical Trials as Topic; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Placebos; Prediabetic State; Research Design; Young Adult | 2009 |
Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes.
Topics: Allylamine; Anticholesteremic Agents; Apolipoproteins B; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Female; Glycated Hemoglobin; Hispanic or Latino; Humans; Hyperlipidemias; Lipoproteins, HDL; Male; Prediabetic State; Treatment Outcome | 2012 |
Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia.
Topics: Adult; Allylamine; Cholesterol, LDL; Colesevelam Hydrochloride; Constipation; Diarrhea; Double-Blind Method; Dyspepsia; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Intention to Treat Analysis; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Nuclear Magnetic Resonance, Biomolecular; Particle Size; Prediabetic State; Triglycerides | 2013 |
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose.
Topics: Aged; Allylamine; Anticholesteremic Agents; Biomarkers; Blood Glucose; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fasting; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Prediabetic State; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2013 |
1 other study(ies) available for allylamine and Prediabetic State
| Article | Year |
|---|---|
Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes.
Topics: Adult; Aged; Allylamine; Anticholesteremic Agents; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prediabetic State; Randomized Controlled Trials as Topic | 2009 |